Monitoring Tacrolimus and Cyclosporine Blood Trough Levels and the Capacity of Anti-oxidant after Kidney Transplantation: A Patent Perspective
This study showed that the capacity of anti-oxidants in kidney transplant recipients, those on tacrolimus or cyclosporine, might be lower than in healthy individuals. Subsequent investigations are recommended to delve into the therapeutic consequences of the influence of antioxidant therapies on the clinical outcomes of transplanted recipients.
Authors
- Zahra Tolou Ghamari (ORCID: https://orcid.org/0000-0003-3994-0211)
Institutions
- Isfahan University of Medical Sciences (IR)
Publication Details
- Journal
- Recent Advances in Inflammation & Allergy Drug Discovery
- Published
- 2024-12-11
- DOI
- https://doi.org/10.2174/0127722708319486241202113259
- Primary Topic
- Pregnancy and Medication Impact
- Type
- article
- Field-Weighted Citation Impact
- 0.00